Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice

This publication has 16 references indexed in Scilit:

• Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia
  Atherosclerosis, 1980
• Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II
  Atherosclerosis, 1980
• Probucol in hypercholesterolemia *1A double blind study
  Atherosclerosis, 1980
• Clofibrate therapy and gallstone induction
  Digestive Diseases and Sciences, 1978
• Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia
  Archives of internal medicine (1960), 1977
• THE TROMSØHEART-STUDY
  The Lancet, 1977
• The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol
  Atherosclerosis, 1973
• Toxicity of [4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol)], probucol, in mice, rats, dogs and monkeys: Demonstration of a species-specific phenomenon
  Toxicology and Applied Pharmacology, 1973
• The effect of [4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects
  Metabolism, 1969
• A colorimetric method for estimating serum triglycerides
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1968